Search Results for: ES cell

Review of Centeno MSC safety paper: without controls, conclusions muted

Centeno-Table-3

The number of people around the world being injected with stem cells every day has never been higher and the heterogeneous group of medical providers doing these procedures is also at or near its highest level ever. The cells used are also highly variable as are the procedures themselves, but most of these cells fall under the

Review of Centeno MSC safety paper: without controls, conclusions muted Read More »

New Paper on CRISPR of Human Embryos Highlights Serious Tech Problems

Human-embryo-CRISPR

A new paper was recently published on CRISPR of human embryos for genetic modification. I’ve got to read this publication more carefully, but here’s a quick initial take on this human CRISPR 2.0 study. The paper is Kang, et al. and is entitled “Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing”.

New Paper on CRISPR of Human Embryos Highlights Serious Tech Problems Read More »

Sexism in Science Naming of Stuff? Bunsen, Petri, Southern, & More

Bunsen-Burner

In science we often use equipment, methods, or units that are named after accomplished scientists of the past without even thinking about it. Originally, this piece was going to be dedicated to those pioneering scientists, but then I realized they are essentially all men with disturbingly few possible exceptions. Is there rampant sexism in science naming at work

Sexism in Science Naming of Stuff? Bunsen, Petri, Southern, & More Read More »

Poll: How do you feel about ‘pay-to-play’ clinical trials?

6a00e55417fcfd8834014e869e537f970d-600wi

There’s a growing trend whereby patients have to pay to be in a clinical trial. This is now widely referred to as “pay-to-play”. Proponents of this idea point toward potential benefits in the form of patients gaining access to innovative therapies. They also argue that this approach provides a much-needed funding mechanism for the trials

Poll: How do you feel about ‘pay-to-play’ clinical trials? Read More »